Kangmei Pharmaceutical Co., Ltd.

SHSE:600518 Stock Report

Market Cap: CN¥36.3b

Kangmei Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 600518?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders54,2480.000391%
Institutions1,568,956,80811.3%
Private Companies3,984,817,28528.7%
General Public8,310,038,34959.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 40.06% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
25.3%
Guangdong Shennong Enterprise Management Partnership (Limited Partnership)
3,509,413,788CN¥9.2b0%no data
4.71%
China Construction Bank Corporation, Asset Management Arm
653,206,909CN¥1.7b0%8.83%
2.25%
Puning Kangmei Industry Co. Ltd.
311,426,409CN¥815.9m0%no data
1.34%
China Everbright Bank Co.,Ltd., Asset Management Arm
186,349,997CN¥488.2m0%54.82%
1.32%
China Minsheng Banking Corp. Ltd., Asset Management Arm
183,387,921CN¥480.5m0%46.3%
1.31%
Guangdong Finance Trust Co., Ltd, Investment Arm
181,818,181CN¥476.4m0%61.06%
1.18%
Wuhu Xintongrui Enterprise Management Center (Limited Partnership)
163,977,088CN¥429.6m0%no data
1.03%
Minmetals International Trust Co., Ltd, Asset Management Arm
142,590,655CN¥373.6m0%34.72%
0.84%
Shenzhen Qianhai Chongming Wanfang Equity Investment Co., Ltd.
116,938,968CN¥306.4m0%no data
0.75%
Shanghai Pudong Development Bank, Asset Management Arm
103,541,540CN¥271.3m0%14.22%
0.0045%
The Vanguard Group, Inc.
627,658CN¥1.6m0%no data
0.0017%
WisdomTree Asset Management, Inc.
230,640CN¥603.0k0%no data
0.00073%
BlackRock, Inc.
100,842CN¥265.2k-14.3%no data
0.00039%
Longtao Huang
54,248CN¥141.7k0%no data
0.00031%
UBS Asset Management AG
43,044CN¥112.6k-0.23%no data
0.00024%
Amundi Asset Management SAS
33,313CN¥87.2k0%no data
0.00018%
Forsta AP-fonden
24,951CN¥65.4k0%no data
0.00013%
Mercer Global Investments Europe Limited
17,476CN¥47.2k0%no data
0.00008%
Northern Trust Global Investments
11,575CN¥29.1k74.8%no data
0.00008%
Deutsche Asset & Wealth Management
10,958CN¥29.1k0%no data
0.00007%
Eaton Vance Management
10,006CN¥25.4k0%no data
0.00003%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
4,044CN¥10.9k-46.6%no data
0.00003%
Aviva Investors Global Services Ltd.
3,525CN¥10.9k0%no data
0.00002%
Mellon Investments Corporation
3,285CN¥7.3k0%no data
0.00001%
Danske Bank A/S, Asset Management Arm
1,296CN¥3.6k0.62%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 09:50
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kangmei Pharmaceutical Co., Ltd. is covered by 17 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Pei Hui TangChasing Securities
Peng ZouChina International Capital Corporation Limited